Literature DB >> 2572846

Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

F Spyratos1, T Maudelonde, J P Brouillet, M Brunet, A Defrenne, C Andrieu, K Hacene, A Desplaces, J Rouëssé, H Rochefort.   

Abstract

122 patients with primary breast cancer were followed-up for a median of 4.6 years after surgery. The concentration of cathepsin D in tumour cytosol was strongly related to both metastasis-free survival and disease-free survival and was independent of nine conventional prognostic indices. Cathepsin D assay may prove particularly useful in identifying women who, though without lymph node involvement at presentation, are at high risk of metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572846     DOI: 10.1016/s0140-6736(89)91487-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  61 in total

1.  Prognostic factors and natural history in lymph node-negative breast cancer patients.

Authors:  R Arriagada; L E Rutqvist; L Skoog; H Johansson; A Kramar
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids.

Authors:  I S Vaithilingam; E C Stroude; W McDonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

3.  Primary medical treatment in breast cancer.

Authors:  Z Rayter; R F Phipps
Journal:  BMJ       Date:  1991-01-05

4.  Post-operative nomogram for predicting freedom from recurrence after surgery in localised breast cancer receiving adjuvant hormone therapy.

Authors:  Chafika Mazouni; Frédéric Fina; Sylvie Romain; Pascal Bonnier; L'houcine Ouafik; Pierre-Marie Martin
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-30       Impact factor: 4.553

5.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

6.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Cathepsin-D expression in cervical carcinoma and its prognostic significance.

Authors:  K M Mitchell; R J Hale; C H Buckley; H Fox; D Smith
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.

Authors:  W Domagala; G Striker; A Szadowska; A Dukowicz; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

9.  Epidermal growth factor receptor in breast cancer: correlation of quantitative immunocytochemical assays to prognostic factors.

Authors:  C Charpin; B Devictor; P Bonnier; L Andrac; M N Lavaut; C Allasia; L Piana
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

Authors:  W Remmele; J Sauer-Manthey
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.